Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125131093 | 12513109 | 3 | F | 20141108 | 20160526 | 20160630 | 20160921 | PER | US-JNJFOC-20160522222 | JANSSEN | 86.47 | YR | E | M | Y | 0.00000 | 20160921 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125131093 | 12513109 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20MG,15MG | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 125131093 | 12513109 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 15 | MG | TABLET | ||||||
| 125131093 | 12513109 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20MG,15MG | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 125131093 | 12513109 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 15 | MG | TABLET | ||||||
| 125131093 | 12513109 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 15 | MG | TABLET | ||||||
| 125131093 | 12513109 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20MG,15MG | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 125131093 | 12513109 | 7 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20MG,15MG | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 125131093 | 12513109 | 8 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 22406 | 15 | MG | TABLET | ||||||
| 125131093 | 12513109 | 9 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | TABLET | ||||||||
| 125131093 | 12513109 | 10 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125131093 | 12513109 | 1 | Embolism |
| 125131093 | 12513109 | 2 | Embolism |
| 125131093 | 12513109 | 3 | Atrial fibrillation |
| 125131093 | 12513109 | 4 | Atrial fibrillation |
| 125131093 | 12513109 | 5 | Cerebrovascular accident prophylaxis |
| 125131093 | 12513109 | 6 | Cerebrovascular accident prophylaxis |
| 125131093 | 12513109 | 7 | Deep vein thrombosis |
| 125131093 | 12513109 | 8 | Deep vein thrombosis |
| 125131093 | 12513109 | 9 | Product used for unknown indication |
| 125131093 | 12513109 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125131093 | 12513109 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125131093 | 12513109 | Anaemia | |
| 125131093 | 12513109 | Melaena |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125131093 | 12513109 | 1 | 20141008 | 2014 | 0 | |
| 125131093 | 12513109 | 2 | 2014 | 20141109 | 0 | |
| 125131093 | 12513109 | 3 | 20141008 | 2014 | 0 | |
| 125131093 | 12513109 | 4 | 2014 | 20141109 | 0 | |
| 125131093 | 12513109 | 5 | 2014 | 20141109 | 0 | |
| 125131093 | 12513109 | 6 | 20141008 | 2014 | 0 | |
| 125131093 | 12513109 | 7 | 20141008 | 2014 | 0 | |
| 125131093 | 12513109 | 8 | 2014 | 20141109 | 0 |